- Chinese hospitals are monetizing de-identified patient data to support the AI industry, with transactions like a Shandong hospital selling liver disease records for 30,000 yuan.
- Government initiatives, such as a 2024 action plan, promote data commercialization in healthcare, leading to sales in Beijing, Fujian, and mandates in Wenzhou.
- Datasets cover areas like cancer, geriatrics, and prenatal care, used by AI firms and researchers for diagnostics and drug development, with strict privacy protections.